CTMX : Insider Transactions for Cytomx Therapeutics, Inc.

Company Profile CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company. Co. is developing an antibody-based therapeutics created using its Probody® therapeutic technology platform. Co.'s products include: Praluzatamab ravtansine, which is an activated antibody-drug conjugates directed against CD166, a tumor target previously considered undruggable due to its high expression on normal tissues; CX-2029, which opens a therapeutic window for targeting CD71; Pacmilimab, which is a Probody therapeutic against PD-L1, a clinically and commercially validated cancer target; and BMS-986249 and BMS-986288, which is the Probody versions of ipilimumab.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	47,819	75,591	103,916	162,805
Total Sell Value	$99,726	$138,068	$174,902	$267,502
Total People Sold	5	5	5	8
Total Sell Transactions	5	10	14	26
End Date	2024-02-04	2023-11-03	2023-05-05	2022-05-05

Adjust Filter Settings

Records found: 286

Page 10 of 12

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Canaan Partners Ix Llc

Director

– • •

2016-11-15

$11.48

$379,476

I/I

(33,064)

3,811,317

Canaan Partners Ix Llc

Director

– • •

2016-11-14

$11.21

$266,056

I/I

(23,744)

3,844,381

Shannon Timothy M

Director

– • –

2016-11-14

$11.21

$266,056

I/I

(23,744)

3,844,381

Canaan Partners Ix Llc

Director

– • •

2016-11-11

$11.20

$396,461

I/I

(35,391)

3,868,125

Shannon Timothy M

Director

– • –

2016-11-11

$11.20

$396,461

I/I

(35,391)

3,868,125

Canaan Partners Ix Llc

Director

– • •

2016-11-10

$11.07

$300,390

I/I

(27,135)

3,903,516

Shannon Timothy M

Director

– • –

2016-11-10

$11.07

$300,390

I/I

(27,135)

3,903,516

Shannon Timothy M

Director

– • –

2016-11-09

$11.03

$151,498

I/I

(13,730)

3,930,651

Canaan Partners Ix Llc

Director

– • •

2016-11-09

$11.03

$151,498

I/I

(13,730)

3,930,651

Exter Neil

Director

– • –

2016-11-07

$0.00

D/D

(0)

Tepper Robert I

10% Owner

– – •

2016-11-07

$0.00

D/D

(1,000,000)

7,670,348

Canaan Partners Ix Llc

Director

– • •

2016-10-11

$0.00

I/I

(300,000)

3,944,381

Goeltz Ii Robert C.

Chief Financial Officer

• – –

2016-09-29

$4.47

$17,891

D/D

4,000

6,000

Gluck Frederick W

Director

– • –

2016-08-09

$0.95

$118,709

D/D

93,124

240,915

Shannon Timothy M

Director

– • –

2016-06-10

$10.01

$27,027

I/I

(2,700)

4,244,381

Canaan Partners Ix Llc

Director

– • •

2016-06-10

$10.01

$27,027

I/I

(2,700)

4,244,381

Shannon Timothy M

Director

– • –

2016-06-09

$10.06

$229,791

I/I

(22,842)

4,247,081

Canaan Partners Ix Llc

Director

– • •

2016-06-09

$10.06

$229,791

I/I

(22,842)

4,247,081

Shannon Timothy M

Director

– • –

2016-06-08

$10.08

$230,681

I/I

(22,885)

4,269,923

Canaan Partners Ix Llc

Director

– • •

2016-06-08

$10.08

$230,681

I/I

(22,885)

4,269,923

Shannon Timothy M

Director

– • –

2016-06-07

$10.03

$97,602

I/I

(9,731)

4,292,808

Canaan Partners Ix Llc

Director

– • •

2016-06-07

$10.03

$97,602

I/I

(9,731)

4,292,808

Shannon Timothy M

Director

– • –

2016-06-06

$10.01

$1,018,688

I/I

(101,767)

4,302,539

Canaan Partners Ix Llc

Director

– • •

2016-06-06

$10.01

$1,018,688

I/I

(101,767)

4,302,539

Canaan Partners Ix Llc

Director

– • •

2016-06-03

$10.83

$199,575

I/I

(18,428)

4,404,306

286 Records found	Previous 10 11 12	Page 10 of 12

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: